{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:00:32Z","timestamp":1780275632159,"version":"3.54.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03813-3","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:47:39Z","timestamp":1776228459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammasomes in glioblastoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Vaidya","family":"Govindarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian K.","family":"Ramsoomair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Aramburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"de Rivero Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"10","key":"3813_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396.","journal-title":"N Engl J Med"},{"issue":"5 Suppl","key":"3813_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","volume":"20","author":"ME Davis","year":"2016","unstructured":"Davis ME. Glioblastoma: Overview of Disease and Treatment. Clin J Oncol Nurs. 2016;20(5 Suppl):S2\u20138.","journal-title":"Clin J Oncol Nurs"},{"key":"3813_CR3","doi-asserted-by":"publisher","first-page":"774014","DOI":"10.3389\/fnmol.2022.774014","volume":"15","author":"B Cyr","year":"2022","unstructured":"Cyr B, et al. The Role of Non-canonical and Canonical Inflammasomes in Inflammaging. Front Mol Neurosci. 2022;15:774014.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"3813_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","volume":"17","author":"V Govindarajan","year":"2020","unstructured":"Govindarajan V, de Rivero JP, Vaccari, Keane RW. Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets. J Neuroinflammation. 2020;17(1):260.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"3813_CR5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","volume":"35","author":"P Broz","year":"2025","unstructured":"Broz P. Pyroptosis: molecular mechanisms and roles in disease. Cell Res. 2025;35(5):334\u201344.","journal-title":"Cell Res"},{"issue":"48","key":"3813_CR6","doi-asserted-by":"publisher","first-page":"e2315503120","DOI":"10.1073\/pnas.2315503120","volume":"120","author":"SA Fattinger","year":"2023","unstructured":"Fattinger SA, et al. Gasdermin D is the only Gasdermin that provides protection against acute Salmonella gut infection in mice. Proc Natl Acad Sci U S A. 2023;120(48):e2315503120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3813_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263.","journal-title":"Signal Transduct Target Ther"},{"key":"3813_CR8","doi-asserted-by":"publisher","first-page":"839041","DOI":"10.3389\/fcell.2022.839041","volume":"10","author":"S Lillo","year":"2022","unstructured":"Lillo S, Saleh M. Inflammasomes in Cancer Progression and Anti-Tumor Immunity. Front Cell Dev Biol. 2022;10:839041.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"3813_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","volume":"19","author":"R Karki","year":"2019","unstructured":"Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19(4):197\u2013214.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3813_CR10","first-page":"vdad009","volume":"5","author":"P Sharma","year":"2023","unstructured":"Sharma P, et al. Tumor microenvironment in glioblastoma: Current and emerging concepts. Neurooncol Adv. 2023;5(1):vdad009.","journal-title":"Neurooncol Adv"},{"issue":"1","key":"3813_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ymthe.2016.10.003","volume":"25","author":"N Kamran","year":"2017","unstructured":"Kamran N, et al. Immunosuppressive Myeloid Cells\u2019 Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy. Mol Ther. 2017;25(1):232\u201348.","journal-title":"Mol Ther"},{"key":"3813_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fimmu.2020.01402","volume":"11","author":"S DeCordova","year":"2020","unstructured":"DeCordova S, et al. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma. Front Immunol. 2020;11:1402.","journal-title":"Front Immunol"},{"issue":"1","key":"3813_CR13","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1038\/s41467-018-05489-7","volume":"9","author":"A Jain","year":"2018","unstructured":"Jain A, et al. T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells. Nat Commun. 2018;9(1):3185.","journal-title":"Nat Commun"},{"issue":"5","key":"3813_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2017.09.039","volume":"171","author":"MM Gaidt","year":"2017","unstructured":"Gaidt MM, et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3. Cell. 2017;171(5):1110\u2013e112418.","journal-title":"Cell"},{"issue":"45","key":"3813_CR15","doi-asserted-by":"publisher","first-page":"18384","DOI":"10.1073\/pnas.1209171109","volume":"109","author":"SK Drexler","year":"2012","unstructured":"Drexler SK, et al. Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis. Proc Natl Acad Sci U S A. 2012;109(45):18384\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3813_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","volume":"14","author":"S Tu","year":"2008","unstructured":"Tu S, et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008;14(5):408\u201319.","journal-title":"Cancer Cell"},{"issue":"1","key":"3813_CR17","doi-asserted-by":"publisher","first-page":"36107","DOI":"10.1038\/srep36107","volume":"6","author":"B Guo","year":"2016","unstructured":"Guo B, et al. Targeting inflammasome\/IL-1 pathways for cancer immunotherapy. Sci Rep. 2016;6(1):36107.","journal-title":"Sci Rep"},{"issue":"7","key":"3813_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"3813_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/cbin.11932","volume":"47","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, et al. USP9X promotes lipopolysaccharide-stimulated acute lung injury by deubiquitination of NLRP3. Cell Biol Int. 2023;47(2):394\u2013405.","journal-title":"Cell Biol Int"},{"key":"3813_CR20","doi-asserted-by":"publisher","unstructured":"McGinley AM et al. Th17 cells, \u03b3\u03b4 T cells and their interplay in EAE and multiple sclerosis. J Autoimmun. 2018 Jan 21:S0896-8411(18)30007-6. https:\/\/doi.org\/10.1016\/j.jaut.2018.01.001","DOI":"10.1016\/j.jaut.2018.01.001"},{"issue":"6","key":"3813_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397\u2013411.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3813_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805\u201320.","journal-title":"Cell"},{"issue":"6996","key":"3813_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature02664","volume":"430","author":"S Mariathasan","year":"2004","unstructured":"Mariathasan S, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature. 2004;430(6996):213\u20138.","journal-title":"Nature"},{"issue":"5","key":"3813_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14(5):454\u201360.","journal-title":"Nat Immunol"},{"issue":"7329","key":"3813_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, et al. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221\u20135.","journal-title":"Nature"},{"key":"3813_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in Cell Death, Inflammation, and Pyroptosis. Annu Rev Immunol. 2020;38:567\u201395.","journal-title":"Annu Rev Immunol"},{"issue":"50","key":"3813_CR27","doi-asserted-by":"publisher","first-page":"41732","DOI":"10.1074\/jbc.M112.381228","volume":"287","author":"PR Vajjhala","year":"2012","unstructured":"Vajjhala PR, Mirams RE, Hill JM. Multiple binding sites on the pyrin domain of ASC protein allow self-association and interaction with NLRP3 protein. J Biol Chem. 2012;287(50):41732\u201343.","journal-title":"J Biol Chem"},{"issue":"7575","key":"3813_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666\u201371.","journal-title":"Nature"},{"issue":"7967","key":"3813_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41586-023-05991-z","volume":"618","author":"M Degen","year":"2023","unstructured":"Degen M, et al. Structural basis of NINJ1-mediated plasma membrane rupture in cell death. Nature. 2023;618(7967):1065\u201371.","journal-title":"Nature"},{"issue":"12","key":"3813_CR30","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4049\/jimmunol.2000373","volume":"204","author":"S Matikainen","year":"2020","unstructured":"Matikainen S, Nyman TA, Cypryk W. Function and Regulation of Noncanonical Caspase-4\/5\/11 Inflammasome. J Immunol. 2020;204(12):3063\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"3813_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","volume":"22","author":"W Xu","year":"2025","unstructured":"Xu W, Huang Y, Zhou R. NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol. 2025;22(4):341\u201355.","journal-title":"Cell Mol Immunol"},{"issue":"7638","key":"3813_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"11","key":"3813_CR33","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1038\/s41380-023-02239-0","volume":"28","author":"J Yao","year":"2023","unstructured":"Yao J, et al. Targeting NLRP3 inflammasome for neurodegenerative disorders. Mol Psychiatry. 2023;28(11):4512\u201327.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"3813_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3813_CR35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41467-025-56097-1","volume":"16","author":"SH Yoon","year":"2025","unstructured":"Yoon SH, et al. Microglial NLRP3-gasdermin D activation impairs blood-brain barrier integrity through interleukin-1\u03b2-independent neutrophil chemotaxis upon peripheral inflammation in mice. Nat Commun. 2025;16(1):699.","journal-title":"Nat Commun"},{"issue":"12","key":"3813_CR36","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/glia.22891","volume":"63","author":"S Johann","year":"2015","unstructured":"Johann S, et al. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia. 2015;63(12):2260\u201373.","journal-title":"Glia"},{"issue":"7","key":"3813_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","volume":"19","author":"R Patani","year":"2023","unstructured":"Patani R, Hardingham GE, Liddelow SA. Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat Rev Neurol. 2023;19(7):395\u2013409.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3813_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/imm.12922","volume":"154","author":"J Stephenson","year":"2018","unstructured":"Stephenson J, et al. Inflammation in CNS neurodegenerative diseases. Immunology. 2018;154(2):204\u201319.","journal-title":"Immunology"},{"key":"3813_CR39","doi-asserted-by":"publisher","unstructured":"de Vaccari R, J.P. and, Keane RW. Neuronal inflammasomes: balancing immunity, neuroinflammation, and homeostasis. Trends in Immunology. 2025 Dec 12:S1471-4906(25)00306-0. https:\/\/doi.org\/10.1016\/j.it.2025.11.007","DOI":"10.1016\/j.it.2025.11.007"},{"key":"3813_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","volume":"252","author":"FL Anderson","year":"2023","unstructured":"Anderson FL, et al. NLRP3 inflammasome in neurodegenerative disease. Transl Res. 2023;252:21\u201333.","journal-title":"Transl Res"},{"key":"3813_CR41","doi-asserted-by":"publisher","first-page":"108803","DOI":"10.1016\/j.pharmthera.2025.108803","volume":"267","author":"W Zhang","year":"2025","unstructured":"Zhang W, et al. Roles of NLRC4 inflammasome in neurological disorders: Mechanisms, implications, and therapeutic potential. Pharmacol Ther. 2025;267:108803.","journal-title":"Pharmacol Ther"},{"key":"3813_CR42","doi-asserted-by":"publisher","unstructured":"Dasdemir E et al. Integrative spatial multi-omics reveal niche-specific inflammatory signaling and differentiation hierarchies in AML. iScience. 2025;29(1):114289. https:\/\/doi.org\/10.1016\/j.isci.2025.114289","DOI":"10.1016\/j.isci.2025.114289"},{"issue":"10","key":"3813_CR43","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41588-021-00926-8","volume":"53","author":"KC Johnson","year":"2021","unstructured":"Johnson KC, et al. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. Nat Genet. 2021;53(10):1456\u201368.","journal-title":"Nat Genet"},{"issue":"1","key":"3813_CR44","doi-asserted-by":"publisher","first-page":"7246","DOI":"10.1038\/s41598-024-56102-5","volume":"14","author":"VJ Marallano","year":"2024","unstructured":"Marallano VJ, et al. Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines. Sci Rep. 2024;14(1):7246.","journal-title":"Sci Rep"},{"issue":"10","key":"3813_CR45","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.cell.2024.03.029","volume":"187","author":"AC Greenwald","year":"2024","unstructured":"Greenwald AC, et al. Integrative spatial analysis reveals a multi-layered organization of glioblastoma. Cell. 2024;187(10):2485\u2013e250126.","journal-title":"Cell"},{"issue":"1","key":"3813_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s43556-024-00179-x","volume":"5","author":"Z Xu","year":"2024","unstructured":"Xu Z, et al. NLRP inflammasomes in health and disease. Mol Biomed. 2024;5(1):14.","journal-title":"Mol Biomed"},{"key":"3813_CR47","doi-asserted-by":"publisher","unstructured":"Gordon R et al. Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med. 2018;10(465):eaah4066. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","DOI":"10.1126\/scitranslmed.aah4066"},{"issue":"6","key":"3813_CR48","doi-asserted-by":"publisher","first-page":"e13834","DOI":"10.1111\/acel.13834","volume":"22","author":"YQ Yan","year":"2023","unstructured":"Yan YQ, et al. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson\u2019s disease. Aging Cell. 2023;22(6):e13834.","journal-title":"Aging Cell"},{"issue":"5","key":"3813_CR49","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni.3389","volume":"17","author":"BN Martin","year":"2016","unstructured":"Martin BN, et al. T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis. Nat Immunol. 2016;17(5):583\u201392.","journal-title":"Nat Immunol"},{"issue":"6292","key":"3813_CR50","doi-asserted-by":"publisher","first-page":"aad1210","DOI":"10.1126\/science.aad1210","volume":"352","author":"G Arbore","year":"2016","unstructured":"Arbore G, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4\u207a T cells. Science. 2016;352(6292):aad1210.","journal-title":"Science"},{"issue":"2","key":"3813_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nri.2015.10","volume":"16","author":"BJ Laidlaw","year":"2016","unstructured":"Laidlaw BJ, Craft JE, Kaech SM. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat Rev Immunol. 2016;16(2):102\u201311.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"3813_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4049\/jimmunol.1403225","volume":"195","author":"Y Yao","year":"2015","unstructured":"Yao Y, et al. Tr1 Cells, but Not Foxp3\u2009+\u2009Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism. J Immunol. 2015;195(2):488\u201397.","journal-title":"J Immunol"},{"issue":"12","key":"3813_CR53","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.4049\/jimmunol.176.12.7278","volume":"176","author":"BJ O\u2019Sullivan","year":"2006","unstructured":"O\u2019Sullivan BJ, et al. IL-1 beta breaks tolerance through expansion of CD25\u2009+\u2009effector T cells. J Immunol. 2006;176(12):7278\u201387.","journal-title":"J Immunol"},{"key":"3813_CR54","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AYW. Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets. Front Cell Neurosci. 2019;13:528.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"3813_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/msj.20104","volume":"76","author":"MW Greve","year":"2009","unstructured":"Greve MW, Zink BJ. Pathophysiology of traumatic brain injury. Mt Sinai J Med. 2009;76(2):97\u2013104.","journal-title":"Mt Sinai J Med"},{"issue":"3","key":"3813_CR56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","volume":"13","author":"DW Simon","year":"2017","unstructured":"Simon DW, et al. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13(3):171\u201391.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"3813_CR57","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1002\/jcp.26287","volume":"233","author":"K Mortezaee","year":"2018","unstructured":"Mortezaee K, et al. Inflammasome: Its role in traumatic brain and spinal cord injury. J Cell Physiol. 2018;233(7):5160\u20139.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3813_CR58","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/cc2950","volume":"9","author":"X Zhang","year":"2005","unstructured":"Zhang X, et al. Bench-to-bedside review: Apoptosis\/programmed cell death triggered by traumatic brain injury. Crit Care. 2005;9(1):66\u201375.","journal-title":"Crit Care"},{"key":"3813_CR59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","volume":"62","author":"K Dasuri","year":"2013","unstructured":"Dasuri K, Zhang L, Keller JN. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med. 2013;62:170\u201385.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3813_CR60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245\u2013313.","journal-title":"Physiol Rev"},{"issue":"1","key":"3813_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-017-0150-7","volume":"12","author":"MW Ma","year":"2017","unstructured":"Ma MW, et al. NADPH oxidase in brain injury and neurodegenerative disorders. Mol Neurodegener. 2017;12(1):7.","journal-title":"Mol Neurodegener"},{"key":"3813_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1742-2094-10-155","volume":"10","author":"SJ Cooney","year":"2013","unstructured":"Cooney SJ, Bermudez-Sabogal SL, Byrnes KR. Cellular and temporal expression of NADPH oxidase (NOX) isotypes after brain injury. J Neuroinflammation. 2013;10:155.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3813_CR63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/NEN.0000000000000021","volume":"73","author":"DJ Loane","year":"2014","unstructured":"Loane DJ, et al. Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation. J Neuropathol Exp Neurol. 2014;73(1):14\u201329.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"3813_CR64","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1007\/s10753-016-0446-8","volume":"39","author":"J Ma","year":"2016","unstructured":"Ma J, et al. Propofol Inhibits NLRP3 Inflammasome and Attenuates Blast-Induced Traumatic Brain Injury in Rats. Inflammation. 2016;39(6):2094\u2013103.","journal-title":"Inflammation"},{"issue":"4","key":"3813_CR65","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11596-016-1628-1","volume":"36","author":"X Wei","year":"2016","unstructured":"Wei X, et al. Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury. J Huazhong Univ Sci Technolog Med Sci. 2016;36(4):576\u201383.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"3813_CR66","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12028-017-0378-7","volume":"27","author":"JS Wallisch","year":"2017","unstructured":"Wallisch JS, et al. Cerebrospinal Fluid NLRP3 is Increased After Severe Traumatic Brain Injury in Infants and Children. Neurocrit Care. 2017;27(1):44\u201350.","journal-title":"Neurocrit Care"},{"issue":"5","key":"3813_CR67","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/01.shk.0000161385.62758.24","volume":"23","author":"T Shiozaki","year":"2005","unstructured":"Shiozaki T, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock. 2005;23(5):406\u201310.","journal-title":"Shock"},{"issue":"3","key":"3813_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00381-004-1032-1","volume":"21","author":"A Chiaretti","year":"2005","unstructured":"Chiaretti A, et al. Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst. 2005;21(3):185\u201393. discussion 194.","journal-title":"Childs Nerv Syst"},{"key":"3813_CR69","doi-asserted-by":"publisher","unstructured":"Dugger BN, Dickson DW. Pathology of Neurodegenerative Diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035. https:\/\/doi.org\/10.1101\/cshperspect.a028035","DOI":"10.1101\/cshperspect.a028035"},{"issue":"6","key":"3813_CR70","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, et al. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334.","journal-title":"Cell"},{"issue":"1","key":"3813_CR71","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"issue":"8","key":"3813_CR72","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol. 2008;9(8):857\u201365.","journal-title":"Nat Immunol"},{"issue":"7434","key":"3813_CR73","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"key":"3813_CR74","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, et al. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice. Brain Behav Immun. 2017;61:306\u201316.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"3813_CR75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44400-025-00011-5","volume":"1","author":"A Auger","year":"2025","unstructured":"Auger A, et al. Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegeneration. npj Dement. 2025;1(1):3.","journal-title":"npj Dement"},{"issue":"6","key":"3813_CR76","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1084\/jem.20182191","volume":"216","author":"N Panicker","year":"2019","unstructured":"Panicker N, et al. Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med. 2019;216(6):1411\u201330.","journal-title":"J Exp Med"},{"issue":"1\u20132","key":"3813_CR77","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160(1\u20132):62\u201373.","journal-title":"Cell"},{"issue":"1","key":"3813_CR78","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12974-022-02410-4","volume":"19","author":"AF Pike","year":"2022","unstructured":"Pike AF, et al. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson\u2019s disease. J Neuroinflammation. 2022;19(1):50.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3813_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s43018-025-01097-9","volume":"7","author":"PM Moreno-Sanchez","year":"2026","unstructured":"Moreno-Sanchez PM, et al. Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity. Nat Cancer. 2026;7(1):29\u201342.","journal-title":"Nat Cancer"},{"issue":"5","key":"3813_CR80","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.3390\/cimb45050272","volume":"45","author":"I Dermitzakis","year":"2023","unstructured":"Dermitzakis I, et al. CNS Border-Associated Macrophages: Ontogeny and Potential Implication in Disease. Curr Issues Mol Biol. 2023;45(5):4285\u2013300.","journal-title":"Curr Issues Mol Biol"},{"issue":"7","key":"3813_CR81","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","volume":"181","author":"E Friebel","year":"2020","unstructured":"Friebel E, et al. Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes. Cell. 2020;181(7):1626\u2013e164220.","journal-title":"Cell"},{"issue":"1","key":"3813_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13073-024-01321-8","volume":"16","author":"YA Yabo","year":"2024","unstructured":"Yabo YA, et al. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts. Genome Med. 2024;16(1):51.","journal-title":"Genome Med"},{"issue":"7","key":"3813_CR83","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","volume":"181","author":"F Klemm","year":"2020","unstructured":"Klemm F, et al. Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells. Cell. 2020;181(7):1643\u2013e166017.","journal-title":"Cell"},{"key":"3813_CR84","doi-asserted-by":"publisher","first-page":"887781","DOI":"10.3389\/fimmu.2022.887781","volume":"13","author":"YJ Lin","year":"2022","unstructured":"Lin YJ, et al. The Role of Myeloid Cells in GBM Immunosuppression. Front Immunol. 2022;13:887781.","journal-title":"Front Immunol"},{"key":"3813_CR85","doi-asserted-by":"publisher","unstructured":"Andersen JK, Miletic H, Hossain JA. Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities. Cancers (Basel). 2022;14(5):1319. https:\/\/doi.org\/10.3390\/cancers14051319","DOI":"10.3390\/cancers14051319"},{"issue":"12","key":"3813_CR86","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/neuonc\/noae139","volume":"26","author":"P Gupta","year":"2024","unstructured":"Gupta P, et al. Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. Neuro Oncol. 2024;26(12):2239\u201355.","journal-title":"Neuro Oncol"},{"issue":"8","key":"3813_CR87","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","volume":"56","author":"A Sattiraju","year":"2023","unstructured":"Sattiraju A, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity. 2023;56(8):1825\u2013e18436.","journal-title":"Immunity"},{"issue":"13","key":"3813_CR88","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1158\/1078-0432.CCR-10-2557","volume":"17","author":"J Lohr","year":"2011","unstructured":"Lohr J, et al. Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-\u03b2. Clin Cancer Res. 2011;17(13):4296\u2013308.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3813_CR89","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","volume":"22","author":"MC Takenaka","year":"2019","unstructured":"Takenaka MC, et al. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019;22(5):729\u201340.","journal-title":"Nat Neurosci"},{"key":"3813_CR90","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.2147\/JIR.S341981","volume":"14","author":"X Guan","year":"2021","unstructured":"Guan X, et al. CTLA4-Mediated Immunosuppression in Glioblastoma is Associated with the Infiltration of Macrophages in the Tumor Microenvironment. J Inflamm Res. 2021;14:7315\u201329.","journal-title":"J Inflamm Res"},{"issue":"1","key":"3813_CR91","first-page":"vdab147","volume":"3","author":"J Blobner","year":"2021","unstructured":"Blobner J, et al. Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes. Neurooncol Adv. 2021;3(1):vdab147.","journal-title":"Neurooncol Adv"},{"issue":"1","key":"3813_CR92","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","volume":"13","author":"VM Ravi","year":"2022","unstructured":"Ravi VM, et al. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022;13(1):925.","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"3813_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0165-5728(01)00361-7","volume":"120","author":"B Badie","year":"2001","unstructured":"Badie B, et al. Expression of Fas ligand by microglia: possible role in glioma immune evasion. J Neuroimmunol. 2001;120(1\u20132):19\u201324.","journal-title":"J Neuroimmunol"},{"issue":"8060","key":"3813_CR94","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41586-025-08633-8","volume":"640","author":"TE Miller","year":"2025","unstructured":"Miller TE, et al. Programs, origins and immunomodulatory functions of myeloid cells in glioma. Nature. 2025;640(8060):1072\u201382.","journal-title":"Nature"},{"issue":"1","key":"3813_CR95","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41467-021-21407-w","volume":"12","author":"N Ochocka","year":"2021","unstructured":"Ochocka N, et al. Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages. Nat Commun. 2021;12(1):1151.","journal-title":"Nat Commun"},{"issue":"17","key":"3813_CR96","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1002\/1878-0261.13287","volume":"16","author":"Y Pires-Afonso","year":"2022","unstructured":"Pires-Afonso Y, et al. Elucidating tumour-associated microglia\/macrophage diversity along glioblastoma progression and under ACOD1 deficiency. Mol Oncol. 2022;16(17):3167\u201391.","journal-title":"Mol Oncol"},{"issue":"1","key":"3813_CR97","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2023.11.032","volume":"187","author":"D Kirschenbaum","year":"2024","unstructured":"Kirschenbaum D, et al. Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma. Cell. 2024;187(1):149\u2013e16523.","journal-title":"Cell"},{"key":"3813_CR98","doi-asserted-by":"crossref","unstructured":"Hofbauer, D., et al., \u03b2\u20092-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression. Immunity, 2021. 54(8): pp. 1772\u20131787.e9.","DOI":"10.1016\/j.immuni.2021.07.002"},{"issue":"6","key":"3813_CR99","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00262-022-03357-4","volume":"72","author":"L Chen","year":"2023","unstructured":"Chen L, et al. NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2023;72(6):1647\u201360.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"3813_CR100","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21(8):485\u201398.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"3813_CR101","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/stem.2393","volume":"34","author":"B Otvos","year":"2016","unstructured":"Otvos B, et al. Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion. Stem Cells. 2016;34(8):2026\u201339.","journal-title":"Stem Cells"},{"issue":"4","key":"3813_CR102","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","volume":"10","author":"JY Sagiv","year":"2015","unstructured":"Sagiv JY, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10(4):562\u201373.","journal-title":"Cell Rep"},{"key":"3813_CR103","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","volume":"222","author":"PC Rodr\u00edguez","year":"2008","unstructured":"Rodr\u00edguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev. 2008;222:180\u201391.","journal-title":"Immunol Rev"},{"issue":"3","key":"3813_CR104","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.immuni.2014.08.015","volume":"41","author":"PT Thevenot","year":"2014","unstructured":"Thevenot PT, et al. The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. Immunity. 2014;41(3):389\u2013401.","journal-title":"Immunity"},{"key":"3813_CR105","doi-asserted-by":"publisher","first-page":"889075","DOI":"10.3389\/fimmu.2022.889075","volume":"13","author":"I Papafragkos","year":"2022","unstructured":"Papafragkos I, et al. Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression. Front Immunol. 2022;13:889075.","journal-title":"Front Immunol"},{"issue":"6","key":"3813_CR106","doi-asserted-by":"publisher","first-page":"153119","DOI":"10.1016\/j.imbio.2025.153119","volume":"230","author":"T Ando","year":"2025","unstructured":"Ando T, et al. ATP\u2013NLRP3 inflammasome axis enhances the immunosuppressive effect of myeloid-derived suppressor cells. Immunobiology. 2025;230(6):153119.","journal-title":"Immunobiology"},{"issue":"8","key":"3813_CR107","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41408-021-00536-x","volume":"11","author":"N Chen","year":"2021","unstructured":"Chen N, et al. Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood Cancer J. 2021;11(8):144.","journal-title":"Blood Cancer J"},{"key":"3813_CR108","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fimmu.2020.00783","volume":"11","author":"A Hou","year":"2020","unstructured":"Hou A, et al. Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors. Front Immunol. 2020;11:783.","journal-title":"Front Immunol"},{"key":"3813_CR109","doi-asserted-by":"publisher","unstructured":"Magri S et al. Sustained Accumulation of Blood-Derived Macrophages in the Immune Microenvironment of Patients with Recurrent Glioblastoma after Therapy. Cancers (Basel). 2021;13(24):6178. https:\/\/doi.org\/10.3390\/cancers13246178","DOI":"10.3390\/cancers13246178"},{"issue":"10","key":"3813_CR110","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00018-019-03048-x","volume":"76","author":"A Salminen","year":"2019","unstructured":"Salminen A, Kaarniranta K, Kauppinen A. Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency. Cell Mol Life Sci. 2019;76(10):1901\u201318.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"3813_CR111","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13402-024-01007-8","volume":"48","author":"K Malone","year":"2025","unstructured":"Malone K, LaCasse E, Beug ST. Cell death in glioblastoma and the central nervous system. Cell Oncol (Dordr). 2025;48(2):313\u201349.","journal-title":"Cell Oncol (Dordr)"},{"issue":"6","key":"3813_CR112","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1523\/JNEUROSCI.22-06-02035.2002","volume":"22","author":"JK Maier","year":"2002","unstructured":"Maier JK, et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci. 2002;22(6):2035\u201343.","journal-title":"J Neurosci"},{"issue":"6","key":"3813_CR113","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3892\/ijmm.2015.2369","volume":"36","author":"E Blahovcova","year":"2015","unstructured":"Blahovcova E, et al. Apoptosis-related gene expression in tumor tissue samples obtained from patients diagnosed with glioblastoma multiforme. Int J Mol Med. 2015;36(6):1677\u201384.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3813_CR114","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1038\/s41598-019-44261-9","volume":"9","author":"J Lim","year":"2019","unstructured":"Lim J, et al. Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients. Sci Rep. 2019;9(1):7895.","journal-title":"Sci Rep"},{"key":"3813_CR115","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.trsl.2018.07.005","volume":"202","author":"F Polito","year":"2018","unstructured":"Polito F, et al. Silencing of telomere-binding protein adrenocortical dysplasia (ACD) homolog enhances radiosensitivity in glioblastoma cells. Transl Res. 2018;202:99\u2013108.","journal-title":"Transl Res"},{"issue":"1","key":"3813_CR116","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/0008-5472.CAN-07-2444","volume":"68","author":"EH Kim","year":"2008","unstructured":"Kim EH, et al. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT\/enhancer-binding protein homologous protein-dependent DR5 up-regulation. Cancer Res. 2008;68(1):266\u201375.","journal-title":"Cancer Res"},{"issue":"2","key":"3813_CR117","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2012.06.015","volume":"332","author":"EC LaCasse","year":"2013","unstructured":"LaCasse EC. Pulling the plug on a cancer cell by eliminating XIAP with AEG35156. Cancer Lett. 2013;332(2):215\u201324.","journal-title":"Cancer Lett"},{"issue":"5","key":"3813_CR118","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1111\/jcmm.17200","volume":"26","author":"J Lin","year":"2022","unstructured":"Lin J, et al. Pyroptosis in glioblastoma: A crucial regulator of the tumour immune microenvironment and a predictor of prognosis. J Cell Mol Med. 2022;26(5):1579\u201393.","journal-title":"J Cell Mol Med"},{"key":"3813_CR119","doi-asserted-by":"publisher","first-page":"1617036","DOI":"10.3389\/fimmu.2025.1617036","volume":"16","author":"X Zheng","year":"2025","unstructured":"Zheng X, et al. The pyroptosis-related gene signature predicts prognosis and reveals immune microenvironment infiltration in reclassified glioblastoma based on 2021 WHO classification. Front Immunol. 2025;16:1617036.","journal-title":"Front Immunol"},{"issue":"1","key":"3813_CR120","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41420-024-02105-0","volume":"10","author":"D Yu","year":"2024","unstructured":"Yu D, et al. EZH2-STAT3 signaling pathway regulates GSDMD-mediated pyroptosis in glioblastoma. Cell Death Discov. 2024;10(1):341.","journal-title":"Cell Death Discov"},{"issue":"3","key":"3813_CR121","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1748-1716.1971.tb04971.x","volume":"82","author":"H Fritz","year":"1971","unstructured":"Fritz H, H\u00e5kanson R. Endotoxin-induced suppression of rabbit kidney DOPA decarboxylase activity. Acta Physiol Scand. 1971;82(3):300\u20139.","journal-title":"Acta Physiol Scand"},{"issue":"1","key":"3813_CR122","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/nyas.13852","volume":"1431","author":"K Vats","year":"2018","unstructured":"Vats K, et al. Inflammasomes in stroke: a triggering role for acid-sensing ion channels. Ann N Y Acad Sci. 2018;1431(1):14\u201324.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"3813_CR123","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/glia.22499","volume":"61","author":"J Minkiewicz","year":"2013","unstructured":"Minkiewicz J, de Rivero JP, Vaccari, Keane RW. Human astrocytes express a novel NLRP2 inflammasome. Glia. 2013;61(7):1113\u201321.","journal-title":"Glia"},{"key":"3813_CR124","doi-asserted-by":"publisher","unstructured":"Chen D et al. Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. J Clin Invest. 2022;132(8):e149258. https:\/\/doi.org\/10.1172\/JCI149258","DOI":"10.1172\/JCI149258"},{"issue":"18","key":"3813_CR125","doi-asserted-by":"publisher","first-page":"18375","DOI":"10.1074\/jbc.M413169200","volume":"280","author":"BJ Conti","year":"2005","unstructured":"Conti BJ, et al. CATERPILLER 16.2 (CLR16.2), a novel NBD\/LRR family member that negatively regulates T cell function. J Biol Chem. 2005;280(18):18375\u201385.","journal-title":"J Biol Chem"},{"issue":"3","key":"3813_CR126","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.4049\/jimmunol.178.3.1256","volume":"178","author":"JD Lich","year":"2007","unstructured":"Lich JD, et al. Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. J Immunol. 2007;178(3):1256\u201360.","journal-title":"J Immunol"},{"issue":"13","key":"3813_CR127","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.cell.2023.05.005","volume":"186","author":"B Sundaram","year":"2023","unstructured":"Sundaram B, et al. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell. 2023;186(13):2783\u2013e280120.","journal-title":"Cell"},{"issue":"1","key":"3813_CR128","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1038\/s41598-019-44854-4","volume":"9","author":"N Sharma","year":"2019","unstructured":"Sharma N, et al. Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma. Sci Rep. 2019;9(1):8480.","journal-title":"Sci Rep"},{"issue":"2","key":"3813_CR129","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jmb.2017.09.019","volume":"430","author":"CL Evavold","year":"2018","unstructured":"Evavold CL, Kagan JC. How Inflammasomes Inform Adaptive Immunity. J Mol Biol. 2018;430(2):217\u201337.","journal-title":"J Mol Biol"},{"issue":"3","key":"3813_CR130","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.4049\/jimmunol.1303051","volume":"194","author":"VM Stoecklein","year":"2015","unstructured":"Stoecklein VM, et al. Radiation exposure induces inflammasome pathway activation in immune cells. J Immunol. 2015;194(3):1178\u201389.","journal-title":"J Immunol"},{"key":"3813_CR131","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fimmu.2014.00197","volume":"5","author":"A Corthay","year":"2014","unstructured":"Corthay A. Does the immune system naturally protect against cancer? Front Immunol. 2014;5:197.","journal-title":"Front Immunol"},{"key":"3813_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fsurg.2016.00011","volume":"3","author":"SM Razavi","year":"2016","unstructured":"Razavi SM, et al. Immune Evasion Strategies of Glioblastoma. Front Surg. 2016;3:11.","journal-title":"Front Surg"},{"issue":"1","key":"3813_CR133","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41698-025-00920-x","volume":"9","author":"W Zhao","year":"2025","unstructured":"Zhao W, et al. Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy. NPJ Precis Oncol. 2025;9(1):126.","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"3813_CR134","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue J, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40(2):274\u201388.","journal-title":"Immunity"},{"issue":"3","key":"3813_CR135","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ni.1990","volume":"12","author":"T Krausgruber","year":"2011","unstructured":"Krausgruber T, et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011;12(3):231\u20138.","journal-title":"Nat Immunol"},{"issue":"4","key":"3813_CR136","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol. 2016;173(4):649\u201365.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"3813_CR137","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677\u201386.","journal-title":"Trends Immunol"},{"issue":"10","key":"3813_CR138","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/neuonc\/noz080","volume":"21","author":"X Guo","year":"2019","unstructured":"Guo X, Pan Y, Gutmann DH. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia. Neuro Oncol. 2019;21(10):1250\u201362.","journal-title":"Neuro Oncol"},{"issue":"9","key":"3813_CR139","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.yexcr.2010.02.018","volume":"316","author":"J Held-Feindt","year":"2010","unstructured":"Held-Feindt J, et al. CX3CR1 promotes recruitment of human glioma-infiltrating microglia\/macrophages (GIMs). Exp Cell Res. 2010;316(9):1553\u201366.","journal-title":"Exp Cell Res"},{"issue":"1","key":"3813_CR140","first-page":"39","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage Divers enhances tumor progression metastasis Cell. 2010;141(1):39\u201351.","journal-title":"Macrophage Divers enhances tumor progression metastasis Cell"},{"key":"3813_CR141","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","volume":"14","author":"AM Jurga","year":"2020","unstructured":"Jurga AM, Paleczna M, Kuter KZ. Overview of General and Discriminating Markers of Differential Microglia Phenotypes. Front Cell Neurosci. 2020;14:198.","journal-title":"Front Cell Neurosci"},{"key":"3813_CR142","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"3813_CR143","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10(11):1387\u201394.","journal-title":"Nat Neurosci"},{"key":"3813_CR144","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fncel.2013.00045","volume":"7","author":"F Ginhoux","year":"2013","unstructured":"Ginhoux F, et al. Origin and differentiation of microglia. Front Cell Neurosci. 2013;7:45.","journal-title":"Front Cell Neurosci"},{"key":"3813_CR145","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3389\/fimmu.2017.01520","volume":"8","author":"SA Amici","year":"2017","unstructured":"Amici SA, Dong J, Guerau-de-Arellano M. Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia. Front Immunol. 2017;8:1520.","journal-title":"Front Immunol"},{"issue":"3","key":"3813_CR146","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00432-024-05625-5","volume":"150","author":"C Zhang","year":"2024","unstructured":"Zhang C, et al. Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2\/STAT3 pathway. J Cancer Res Clin Oncol. 2024;150(3):168.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3813_CR147","first-page":"vdaa043","volume":"2","author":"B Lohmann","year":"2020","unstructured":"Lohmann B, et al. Interferon-\u03b2 exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity. Neurooncol Adv. 2020;2(1):vdaa043.","journal-title":"Neurooncol Adv"},{"issue":"6","key":"3813_CR148","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, et al. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol. 2019;15(6):556\u20139.","journal-title":"Nat Chem Biol"},{"key":"3813_CR149","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.trsl.2022.06.016","volume":"251","author":"R de Vaccari","year":"2023","unstructured":"de Vaccari R. Mechanism of action of IC 100, a humanized IgG4 monoclonal antibody targeting apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC). Transl Res. 2023;251:27\u201340.","journal-title":"Transl Res"},{"issue":"1","key":"3813_CR150","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12974-020-01826-0","volume":"17","author":"HL Desu","year":"2020","unstructured":"Desu HL, et al. IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis. J Neuroinflammation. 2020;17(1):143.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3813_CR151","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10456-024-09917-9","volume":"27","author":"H Yuan","year":"2024","unstructured":"Yuan H, et al. IC100, a humanized therapeutic monoclonal anti-ASC antibody alleviates oxygen-induced retinopathy in mice. Angiogenesis. 2024;27(3):423\u201340.","journal-title":"Angiogenesis"},{"issue":"3","key":"3813_CR152","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy TF, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med. 2019;25(3):477\u201386.","journal-title":"Nat Med"},{"issue":"7","key":"3813_CR153","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","volume":"6","author":"DA Reardon","year":"2020","unstructured":"Reardon DA, et al. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2020;6(7):1003\u201310.","journal-title":"JAMA Oncol"},{"issue":"7655","key":"3813_CR154","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545(7655):495\u20139.","journal-title":"Nature"},{"key":"3813_CR155","doi-asserted-by":"publisher","first-page":"588552","DOI":"10.3389\/fimmu.2020.588552","volume":"11","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, et al. PD-L1-Mediated Immunosuppression in Glioblastoma Is Associated With the Infiltration and M2-Polarization of Tumor-Associated Macrophages. Front Immunol. 2020;11:588552.","journal-title":"Front Immunol"},{"issue":"1","key":"3813_CR156","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/s41598-022-06430-1","volume":"12","author":"J Fierro Jr","year":"2022","unstructured":"Fierro J Jr., et al. Dual-sgRNA CRISPR\/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization. Sci Rep. 2022;12(1):2417.","journal-title":"Sci Rep"},{"issue":"10105","key":"3813_CR157","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, et al. Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(10105):1833\u201342.","journal-title":"Lancet"},{"issue":"8","key":"3813_CR158","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793\u2013800.","journal-title":"Nat Med"},{"issue":"9948","key":"3813_CR159","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","volume":"384","author":"C Robert","year":"2014","unstructured":"Robert C, et al. Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet. 2014;384(9948):1109\u201317.","journal-title":"Lancet"},{"key":"3813_CR160","doi-asserted-by":"publisher","first-page":"108512","DOI":"10.1016\/j.intimp.2021.108512","volume":"104","author":"Y Ding","year":"2022","unstructured":"Ding Y, et al. NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis. Int Immunopharmacol. 2022;104:108512.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3813_CR161","doi-asserted-by":"publisher","first-page":"24753","DOI":"10.1038\/s41598-024-75805-3","volume":"14","author":"L-R Balahura St\u0103mat","year":"2024","unstructured":"Balahura St\u0103mat L-R, Dinescu S. Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment. Sci Rep. 2024;14(1):24753.","journal-title":"Sci Rep"},{"issue":"1","key":"3813_CR162","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41698-024-00753-0","volume":"8","author":"S Park","year":"2024","unstructured":"Park S, Maus MV, Choi BD. CAR-T cell therapy for the treatment of adult high-grade gliomas. npj Precision Oncol. 2024;8(1):279.","journal-title":"npj Precision Oncol"},{"issue":"1","key":"3813_CR163","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1038\/s41467-025-56930-7","volume":"16","author":"S-P Weathers","year":"2025","unstructured":"Weathers S-P, et al. Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I\/II trial. Nat Commun. 2025;16(1):3950.","journal-title":"Nat Commun"},{"issue":"2","key":"3813_CR164","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1080\/21645515.2020.1782692","volume":"17","author":"T Yang","year":"2021","unstructured":"Yang T, Kong Z, Ma W. PD-1\/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential. Hum Vaccin Immunother. 2021;17(2):546\u201353.","journal-title":"Hum Vaccin Immunother"},{"issue":"Supplement 1","key":"3813_CR165","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1182\/blood-2025-5901","volume":"146","author":"X Huang","year":"2025","unstructured":"Huang X, et al. Reducing Acute Myeloid Leukemia resistance to CAR T cell therapy by epigenetic activation of the tumor inflammasome-pyroptosis signaling. Blood. 2025;146(Supplement 1):5901\u20135901.","journal-title":"Blood"},{"issue":"1","key":"3813_CR166","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2023.11.013","volume":"36","author":"A Rashidi","year":"2024","unstructured":"Rashidi A, et al. Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth. Cell Metabol. 2024;36(1):62\u2013e778.","journal-title":"Cell Metabol"},{"issue":"1","key":"3813_CR167","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41597-023-02365-y","volume":"10","author":"S-C Kim","year":"2023","unstructured":"Kim S-C, et al. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue. Sci Data. 2023;10(1):448.","journal-title":"Sci Data"},{"key":"3813_CR168","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3389\/fimmu.2018.01329","volume":"9","author":"KA Walentynowicz","year":"2018","unstructured":"Walentynowicz KA, et al. In Search for Reliable Markers of Glioma-Induced Polarization of Microglia. Front Immunol. 2018;9:1329.","journal-title":"Front Immunol"},{"issue":"12","key":"3813_CR169","doi-asserted-by":"publisher","first-page":"101770","DOI":"10.1016\/j.isci.2020.101770","volume":"23","author":"EA Akins","year":"2020","unstructured":"Akins EA, Aghi MK, Kumar S. Incorporating Tumor-Associated Macrophages into Engineered Models of Glioma. iScience. 2020;23(12):101770.","journal-title":"iScience"},{"key":"3813_CR170","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2020.01191","volume":"11","author":"TJ Alban","year":"2020","unstructured":"Alban TJ, et al. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression. Front Immunol. 2020;11:1191.","journal-title":"Front Immunol"},{"key":"3813_CR171","doi-asserted-by":"publisher","unstructured":"Keane RW et al. Neural-Cardiac Inflammasome Axis after Traumatic Brain Injury. Pharmaceuticals (Basel). 2023;16(10):1382. https:\/\/doi.org\/10.3390\/ph16101382","DOI":"10.3390\/ph16101382"},{"issue":"7","key":"3813_CR172","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/jcbfm.2009.46","volume":"29","author":"R de Vaccari","year":"2009","unstructured":"de Vaccari R. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab. 2009;29(7):1251\u201361.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"13","key":"3813_CR173","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1523\/JNEUROSCI.0157-08.2008","volume":"28","author":"JP de Rivero Vaccari","year":"2008","unstructured":"de Rivero Vaccari JP, et al. A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci. 2008;28(13):3404\u201314.","journal-title":"J Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03813-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03813-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03813-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:02:06Z","timestamp":1780272126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03813-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":173,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03813-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JPdRV and RWK are co-founders and managing members of InflamaCORE, LLC and have licensed patents on inflammasome proteins as biomarkers of injury and disease as well as on targeting inflammasome proteins for therapeutic purposes. JPdRV and RWK are Scientific Advisory Board Members of ZyVersa Therapeutics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}